Gautschi O, Park K, Solomon BJ, Tomasini P, et al. Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial. J Clin Oncol 2025 Feb 21:JCO2402076. doi: 10.1200/JCO-24-02076.
PMID: 39983053